From the ‘scurfy’ mouse to the Nobel Prize: How a Seattle biotech pioneer’s long game paid off From a Bill Gates-backed startup in the mid ’90s to the Nobel stage in 2025, Fred Ramsdell reveals how “patient capital” and a mutation found in a 1940s mouse helped unlock immune system secrets. Read More
The mother of all treatments: Mitera lands $1.75M to unlock the immune-tolerance secrets of pregnancy Mitera Biosciences is emerging from stealth with a mission to develop new drugs for autoimmune diseases and organ transplant rejection. Read More
